2015

1. Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

   Neuropathology and Applied Neurobiology, Vol. 41, Núm. 4, pp. 471-482